MDT Stock Gains From FDA Approval for Its InPen App [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
This latest FDA clearance should pave the way for the launch of the company's Smart MDI system, which combines the InPen smart insulin pen with its newest Simplera continuous glucose monitor (CGM). Medtronic will initiate a limited market release with existing standalone CGM and InPen customers, followed by a broad commercial launch. Subsequent to the news, the share price of MDT moved north 0.7% to $84.74 yesterday. The latest development is likely to boost the company's Diabetes segment. The company is gaining a high level of synergies from its continuous effort to develop diabetes management products. Medtronic is experiencing continued adoption of the MiniMed 780G automated insulin delivery system, along with increasing CGM attachment rates and the continued rollout of Simplera Sync. Accordingly, we expect market sentiment toward MDT stock to continue to remain positive surrounding this news. Medtronic boasts a market capitalization of $116.20 billion. The company delivere
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed expands Singapore operations to address obstructive sleep conditions [CNBC]CNBC
- This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar [Yahoo! Finance]Yahoo! Finance
- Rebalance Health Demonstrates Significant Sleep Benefits in New Blind Placebo Study [Yahoo! Finance]Yahoo! Finance
- ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders [Yahoo! Finance]Yahoo! Finance
- Here's Why You Should Add RMD Stock to Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 10/24/24 - Beat
RMD
Sec Filings
- 11/22/24 - Form 144
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- RMD's page on the SEC website